{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/9436211",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/531667506"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#9436211",
  "code": "3A50.02",
  "source": "http://id.who.int/icd/entity/9436211",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Haemoglobin H disease (– α/– – included)"
  },
  "definition": {
    "@language": "en",
    "@value": "Haemoglobin H (HbH) disease is a moderate to severe form of alpha-thalassemia characterised by pronounced microcytic hypochromic haemolytic anaemia."
  },
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1426960900"
  ],
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/1148519290"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Haemoglobin H disease (– α/– – included)"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "alpha - /- - or mutational forms of alpha-thalassaemia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Alpha thalassaemia intermedia"
      }
    }
  ]
}